- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
EyeYon Medical spies series C investors
The ophthalmic treatment developer has now raised almost $36m in total, with CR-CP Life Science Fund having led a $25m round.
Mar 16, 2021Cuorips captures $14.7m
Osaka spinout Cuorips has added $14.7m to its coffers from investors including vehicles for the institution and Kyoto University, just three months after collecting $19.3m.
Mar 16, 2021Cruise takes Voyage in acquisition deal
Autonomous taxi developer Voyage had received a total of $52m from investors including InMotion Ventures and Chevron Technology Ventures.
Mar 16, 2021WndrCo gets seat at Airtable in $270m round
The database software provider more than doubled its valuation to nearly $5.8bn in a series E round that boosted its cash on hand to about $500m.
Mar 16, 2021Insitro intercepts $400m
Softbank Investment Advisors and existing investor GV contributed to a series C round boosting the drug discovery platform developer's overall funding to over $640m.
Mar 16, 2021CureApp gets funding treatment
The Keio University-backed digital medicine developer has secured $19.3m from a consortium including several Japanese corporations.
Mar 16, 2021CureApp gets funding treatment
Dai-ichi Life, Itochu Technology Ventures, Koshidaka and Toyoshima CVC were among the investors that backed the medical therapy booking platform’s $19.3m round.
Mar 16, 2021Kunlun climbs to $2bn valuation
Legend Capital was among the investors in a round of undisclosed size for Kunlun, an AI chip subsidiary of Baidu, at a valuation of about $2bn.
Mar 16, 2021Alvotech amplifies private placement to $100m
Baxter Healthcare was among the investors in the $65m first close of a private placement the biosimilar drug developer has pushed to $100m.
Mar 16, 2021Monte Rosa scales $95m series C
Alphabet subsidiary GV was part of a consortium in a round that will fund the progress of the precision medicine developer's lead drug candidate into the clinic.
Mar 16, 2021Skeleton Technologies powers up with $61m
The Harju Elekter-backed ultracapacitor producer will develop automated production technology with funding secured from the German government.
Mar 16, 2021Terminus turns to Alibaba in series A round
Alibaba Cloud's stake in the digitalisation technology provider now stands at over 31% following the latter's $61.5m series A round.
Mar 16, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


